Characteristics | Overall (n = 163) | Tertile-1 (n = 54) | Tertile-2 (n = 55) | Tertile-3 (n = 54) | P-Value For trend |
---|---|---|---|---|---|
Infarct-related Measures | |||||
AAR (g) | 23 ± 12 | 20 ± 12 | 23 ± 11 | 25 ± 13 | 0.113 |
AAR (% LV) | 18 ± 8 | 17 ± 9 | 19 ± 9 | 18 ± 8 | 0.385 |
IMH n, (%) | 46 (28) | 12 (22) | 17 (31) | 17 (31) | 0.487 |
IMH extent (g) | 2.8 (1.6–5.4) | 2.8 (1.5–9.2) | 3.0 (2.1–4.8)8 | 2.4 (1.1–5.4) | 0.794 |
IMH extent (% of LV) | 2.0 (1.0–4.1) | 2.7 (1.0–7.2) | 2.4 (1.3–3.9) | 1.9 (0.8–3.9)1 | 0.681 |
Infarct size (g) | 16 ± 13 | 15 ± 12 | 16 ± 12 | 19 ± 14 | 0.271 |
Infarct size (% of LV) | 13 ± 9 | 12 ± 9 | 12 ± 9 | 14 ± 9 | 0.646 |
MVO n, (%) | 73 (45) | 23 (43) | 25 (46) | 25 (46) | 0.921 |
MVO extent (g) | 4.0 (2.3–7.9) | 3.0 (2.0–4.2) | 5.6 (3.0–7.8) | 5.0 (2.3–11.4) | 0.294 |
MVO extent (% of LV) | 3.8 (1.8–6.9) | 2.5 (1.5–4.5) | 4.4 (2.0–6.9) | 3.8 (1.9–8.0) | 0.426 |
MSI (%) | 31 (7–55) | 24(8–48) | 36 (8–58) | 26 (1–51) | 0.258 |
LV functional Parameters | |||||
LV-EDVi (ml/m2) | 75 ± 19 | 71 ± 17 | 75 ± 18 | 80 ± 21 | 0.042 |
LV-ESVi (ml/m2) | 35 ± 19 | 33 ± 13 | 34 ± 18 | 40 ± 22 | 0.068 |
LV-EF (%) | 50 ± 12 | 51 ± 11 | 52 ± 11 | 48 ± 15 | 0.198 |
LV-Mi (g/m2) | 66 ± 15 | 63 ± 15 | 67 ± 15 | 69 ± 15 | 0.129 |
RelaxationTimes | |||||
T2-mapping | |||||
T2 infarct (ms) | 62.8 ± 6.4 | 60.0 ± 4.9†• | 63.5 ± 5.6• | 64.8 ± 7.5† | < 0.001 |
T2 remote (ms) | 45.5 ± 3.0 | 44.3 ± 2.8•* | 46.1 ± 2.8• | 46.1 ± 3.0* | 0.001 |
T2 infarct core (ms) | 47.0 (44.9–50.0) | 47.5 (46.0–49.7) | 45.8 (42.6–48.5) | 48.0 (45.8–50.6) | 0.071 |
T1-mapping* | |||||
T1 infarct (ms)* | 1220 ± 81 | 1172 ± 63†• | 1235 ± 78• | 1248 ± 82† | < 0.001 |
T1 remote (ms)* | 1019 ± 59 | 1004 ± 37 | 1019 ± 54 | 1034 ± 76 | 0.076 |
ECV infarct (%)** | 46.7 (41.5–52.0) | 49.0 (41.6–53.1) | 45.6 (41.7–52.9) | 45.9 (40.1–49.5) | 0.470 |
ECV remote (%)** | 24.5 (22.1–27.1) | 25.2 (22.0–27.0) | 23.9 (22.3–25.7) | 24.6 (22.0–28.3) | 0.916 |